MammaPrint Feasibility in a Large Tertiary Urban Medical Center: An Initial Experience

Background. The MammaPrint (MP) diagnostic assay stratifies breast cancer patients into high- and low-risk groups using mRNA analysis of a 70-gene profile. The assay is validated for assessment of patients with estrogen receptor positive or negative tumors less than 5 cm with 3 or fewer malignant ly...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Espinel, C. Francisco, Keating, Shaughn, Hibshoosh, Hanina, Taback, Bret, Joseph, Kathie-Ann, El-Tamer, Mahmoud, Feldman, Sheldon
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Hindawi Publishing Corporation 2012
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3820467/
https://ncbi.nlm.nih.gov/pubmed/24278759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6064/2012/942507
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items